Moderate to Severe Ulcerative Colitis: Clinical Trials

2 trials for Moderate to Severe Ulcerative Colitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Not yet recruiting 1

Follow Moderate to Severe Ulcerative Colitis: new trials by email Literature Review of Moderate to Severe Ulcerative Colitis trials Research Report on Moderate to Severe Ulcerative Colitis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Trial of HRS-7085 Tablets in Patients With Moderate to Severe Active Ulcerative Colitis
HRS-7085 tablets, Placebo - Moderate to Severe Ulcerative Colitis
Phase 1Not yet recruitingJiangsu HengRui Medicine Co., Ltd.82026-08-012026-08-12
A Study to Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulcerative Colitis
Vixarelimab - Moderate to Severe Ulcerative Colitis
Phase 1CompletedGenentech, Inc.242025-03-312026-09-21

Sponsors

Genentech, Inc. (1)  ·  Jiangsu HengRui Medicine Co., Ltd. (1)

Countries

Germany (1)  ·  Moldova (1)